Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Hypericin regulatory update

February 3, 2017 12:42 AM UTC

The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) granted promising innovative medicine (PIM) designation to SGX301 to treat cutaneous T cell lymphoma (CTCL). SGX301 is a topical pho...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Soligenix Inc.

BCIQ Target Profiles

Heat shock protein 90 (Hsp90)